Mogle BT - Search Results

1

Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection.

Beccari MV, Mogle BT, Sidman EF, Mastro KA, Asiago-Reddy E, Kufel WD. Beccari MV, et al. Among authors: mogle bt. Antimicrob Agents Chemother. 2019 May 24;63(6):e00110-19. doi: 10.1128/AAC.00110-19. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30885900 Free PMC article. Review.

2

Clinical review of delafloxacin: a novel anionic fluoroquinolone.

Mogle BT, Steele JM, Thomas SJ, Bohan KH, Kufel WD. Mogle BT, et al. J Antimicrob Chemother. 2018 Jun 1;73(6):1439-1451. doi: 10.1093/jac/dkx543. J Antimicrob Chemother. 2018. PMID: 29425340 Review.

3

Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Mogle BT, Steele JM, Seabury RW, Dang UJ, Kufel WD. Mogle BT, et al. Int J Antimicrob Agents. 2018 Dec;52(6):805-810. doi: 10.1016/j.ijantimicag.2018.08.024. Epub 2018 Aug 31. Int J Antimicrob Agents. 2018. PMID: 30176357

4

In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis.

Kufel WD, Eranki AP, Paolino KM, Call A, Miller CD, Mogle BT. Kufel WD, et al. Among authors: mogle bt. J Antimicrob Chemother. 2019 Jul 1;74(7):2117-2118. doi: 10.1093/jac/dkz103. J Antimicrob Chemother. 2019. PMID: 30863839 No abstract available.

5

Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections.

Mogle BT, Beccari MV, Steele JM, Fazili T, Kufel WD. Mogle BT, et al. Expert Opin Pharmacother. 2019 Jun;20(8):903-907. doi: 10.1080/14656566.2019.1594774. Epub 2019 Mar 25. Expert Opin Pharmacother. 2019. PMID: 30908107 No abstract available.

6

Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium.

Kufel WD, Seabury RW, Mogle BT, Beccari MV, Probst LA, Steele JM. Kufel WD, et al. Among authors: mogle bt. Am J Health Syst Pharm. 2019 Jun 3;76(12):889-894. doi: 10.1093/ajhp/zxz070. Am J Health Syst Pharm. 2019. PMID: 31063582

7

Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.

Beccari MV, Seabury RW, Mogle BT, Kufel WD, Miller CD, Steele JM. Beccari MV, et al. Among authors: mogle bt. J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):729-733. doi: 10.1016/j.japh.2020.02.025. Epub 2020 Mar 26. J Am Pharm Assoc (2003). 2020. PMID: 32224054

8

Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin.

Steele JM, Seabury RW, Hale CM, Mogle BT. Steele JM, et al. Among authors: mogle bt. J Clin Pharm Ther. 2018 Feb;43(1):101-103. doi: 10.1111/jcpt.12580. Epub 2017 Jun 19. J Clin Pharm Ther. 2018. PMID: 28628223

9

The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey.

Mogle BT, Seabury RW, Jones Z, Miller CD, Steele JM. Mogle BT, et al. Hosp Pharm. 2019 Jun;54(3):175-179. doi: 10.1177/0018578718775328. Epub 2018 May 8. Hosp Pharm. 2019. PMID: 31205328 Free PMC article.

10

Severe neutrophilic dermatosis following submental deoxycholic acid administration.

Mogle BT, Seabury RW, Jennings S, Cwikla GM. Mogle BT, et al. Clin Toxicol (Phila). 2017 Aug;55(7):681. doi: 10.1080/15563650.2017.1306071. Epub 2017 Apr 10. Clin Toxicol (Phila). 2017. PMID: 28394637 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters